4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-008609
PRESIDENT AND CEO sold 12,500 shares at $20.83 ($260,320)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kintz Samuel · PRESIDENT AND CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-17 | Sale : show line 1 in the form 10b5-1 | −12,500 | $20.83 | $260,320 | 990,392 | I |
| Open-market sales · 12,500 sh · avg $20.83 · $260,320 | ||||||
Loading xslF345X05/form4-03192025_090346.xml…